Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines

Archives of Dermatological Research

Volumn 301, Issue 8, 2009, Pages 553-559

  Nast, Alexander ^a   Erdmann, R ^a   Hofelich, V ^a   Reytan, N ^a   Orawa, H ^a   Sterry, W ^a   Rzany, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Evaluation; Guidelines; Prescription; Psoriasis; Treatment

Indexed keywords

CALCINEURIN INHIBITOR; COAL TAR; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EFALIZUMAB; ETANERCEPT; ETRETIN; FUMARIC ACID; INFLIXIMAB; METHOTREXATE; SALICYLIC ACID; TAZAROTENE; VITAMIN D;

ADULT; AGED; ARTICLE; ATTITUDE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; DERMATOLOGY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; GERMANY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSPECTIVE STUDY; PSORIASIS; PUBLICATION; PUVA; QUESTIONNAIRE; TREATMENT INDICATION; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTIONS; PROSPECTIVE STUDIES; PSORIASIS;

EID: 69049100995     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0978-y     Document Type: Article

References (17)

1. M Augustin 2008 PsoNet: more health care quality through regional psoriasis networks J Dtsch Dermatol Ges 6 4 263 264
2. M Augustin K Reich C Reich, et al. 2008 Quality of psoriasis care in Germany: results of the national study PsoHealth 2007 J Dtsch Dermatol Ges 6 8 640 645
3. CBO (2003) Richtlijn foto(chemo)therapie en systemische therapie bij ernstige chronische plaque psoriasis. Van Zuiden Communications
4. Dootz H, Kuhlmann A, Hoffmann K et al. (2006) Rote Liste 2006. Frankfurt am Main: Rote Liste Service GmbH
5. Dootz H, Kuhlmann A, Hoffmann K et al. (2007) Rote Liste 2007. Frankfurt am Main: Rote Liste Service GmbH; 2007
6. W Hoffmann U Latza C Terschuren 2005 Guidelines and recommendations for ensuring good epidemiological practice (GEP): revised version after evaluation Gesundheitswesen 67 3 217 225
7. EJ Horn KM Fox V Patel, et al. 2007 Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey J Am Acad Dermatol 57 6 957 962
8. G Krueger J Koo M Lebwohl, et al. 2001 The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey Arch Dermatol 137 3 280 284
9. A Nast R Erdmann D Pathirana, et al. 2008 Translating psoriasis treatment guidelines into clinical practice-the need for educational interventions and strategies for broad dissemination J Eval Clin Pract 14 5 803 806
10. A Nast I Kopp M Augustin, et al. 2007 German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) Arch Dermatol Res 299 3 111 138
11. A Nast IB Kopp M Augustin, et al. 2006 S3-Guidelines for the therapy of psoriasis vulgaris J Dtsch Dermatol Ges 4 Suppl 2 S1 S126
12. A Nast N Reytan S Rosumeck, et al. 2008 Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry J Eur Acad Dermatol Venereol 22 11 1337 1342
13. A Nast N Reytan S Rosumeck, et al. 2007 Zeitaufwand und Kosten bei der Erstellung der S3-Leitlinie zur Therapie der Psoriasis vulgaris J Dtsch Dermatol Ges 5 s2 198
14. HL Richards DG Fortune TM O'Sullivan, et al. 1999 Patients with psoriasis and their compliance with medication J Am Acad Dermatol 41 4 581 583
15. CH Smith AV Anstey JN Barker AD Burden RJ Chalmers D Chandler AY Finlay CE Griffiths K Jackson NJ McHugh KE McKenna NJ Reynolds AD Ormerod 2005 British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005 Br J Dermatol 153 486 497
16. RS Stern T Nijsten SR Feldman, et al. 2004 Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2 136 139
17. M Wakkee M Lugtenberg PI Spuls, et al. 2008 Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists Br J Dermatol 159 2 426 432